The UNC-Duke Collaborative Clinical Pharmacology T32 Postdoctoral Training Program is a collaboration between the UNC Eshelman School of Pharmacy and the Duke Clinical Research Institute to prepare clinician-scientists to become leaders in clinical pharmacology research. This two-year program meets the fellowship training expectations set forth by the American Board of Clinical Pharmacology and is a registered member of ABCP. Clinical pharmacology, in the broadest sense, encompasses drug discovery, clinical development, regulatory issues, therapeutic use and individualization of drug therapy, optimization of drug dosage regimens, an understanding of drug-induced toxicity, and measures to prevent or minimize adverse effects of drugs.

- Preferred candidates will have strong publication record and demonstrated experience in research study design and project implementation.